bosentan anhydrous has been researched along with Histiocytosis, Langerhans-Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujimi, K; Fukuda, Y; Hiratsuka, M; Iwasaki, A; Miura, S; Nishikawa, H; Saku, K; Shiraishi, T; Yanagisawa, J; Yano, M | 1 |
| Cordier, JF; Cottin, V; Etienne-Mastroïanni, B; Humbert, M; Khouatra, C; Kiakouama, L | 1 |
2 other study(ies) available for bosentan anhydrous and Histiocytosis, Langerhans-Cell
| Article | Year |
|---|---|
Effects of treatment with a combination of cardiac rehabilitation and bosentan in patients with pulmonary Langerhans cell histiocytosis associated with pulmonary hypertension.
Topics: Adult; Antihypertensive Agents; Bosentan; Endothelin Receptor Antagonists; Exercise Therapy; Exercise Tolerance; Female; Heart Failure; Hemodynamics; Histiocytosis, Langerhans-Cell; Humans; Hypertension, Pulmonary; Positron-Emission Tomography; Recovery of Function; Sulfonamides; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Severe pulmonary hypertension in histiocytosis X: long-term improvement with bosentan.
Topics: Antihypertensive Agents; Bosentan; Dyspnea; Hemodynamics; Histiocytosis, Langerhans-Cell; Humans; Hypertension, Pulmonary; Male; Middle Aged; Piperazines; Purines; Severity of Illness Index; Sildenafil Citrate; Sulfonamides; Sulfones | 2010 |